Growth factor-dependent and -independent activation of mTORC2
Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
The target of rapamycin complex 2 (TORC2) was discovered in 2002 in budding yeast. Its mammalian counterpart, mTORC2, was first described in 2004. Soon thereafter it was demonstrated that mTORC2 directly phosphorylates Akt on Ser473, ending a long search for the elusive 'second' insulin-responsive Akt kinase. In this review we discuss key evidence pertaining to the subcellular localization of mTORC2, highlighting a spatial heterogeneity that relates to mTORC2 activation. We summarize current models for how growth factors (GFs), such as insulin, trigger mTORC2 activation, and we provide a comprehensive discussion focusing on a new exciting frontier, the molecular mechanisms underpinning GF-independent activation of mTORC2.
|Tidsskrift||Trends in Endocrinology and Metabolism|
|Status||E-pub ahead of print - 4 nov. 2019|
CURIS 2019 NEXS 352
Copyright © 2019 Elsevier Ltd. All rights reserved.